Posted in Health and Wellness, Technology Company

Elysium Health Breaks Ground with Basis

Elysium Health was co-founded in 2014 by the MIT research scientist Dr. Leonard Guarente. The company was built on the idea of translating advances in science and technology into clinically-validated health products that work.

The guarantee has long worked at the forefront of aging research. During his long career as the director of MIT’s Paul F. Glenn Center for Biology of Aging Research, Guarente has conducted significant research on the molecular and genetic causes of aging.

Elysium Health collaborates with world-class scientists and clinicians from universities such as Stanford, Yale, and Harvard. These prestigious scientists make up the company’s scientific board of advisors and guide the path of the company’s research and development.

Elysium Health’s first product, Basis, is based on more than 25 years of aging research. Basis works by increasing levels of a critical coenzyme called NAD+, which stands for nicotinamide adenine dinucleotide. NAD+ is crucial to hundreds of our cellular functions, including circadian rhythms, DNA protection, and energy creation.

As people age, their levels of NAD+ decline and the functions to which it is essential to break down. That is why Basis is designed to increase levels of NAD+ and support our cellular health as a result.

The basis is available on Elysium Health’s website. It costs $50 for a one-month supply if you choose to purchase a standard monthly subscription. Longer subscriptions cost more upfront but offer discounts on the monthly rate. Each jar contains 60 capsules (the recommended daily intake is two capsules). An individual jar costs $60 without a subscription.

Basis can be taken while even if you have allergies or are on a diet, because the supplement is vegetarian, vegan, gluten-free, nut-free, and is free of any artificial flavors and colors.

More information on Elysium Health, the company’s team, and the science behind Basis can be found on Elysium’s website.

Posted in Health and Wellness

Here’s Some Insight into Elysium Health and its Basis

Supplements are found all across the United States – in grocery stores, supermarkets, health food vendors, supplement shops. Yet most of them are not backed by the rigorous research of clinical trials. This can’t be said for Elysium Health’s Basis, a supplement crafted from nicotinamide riboside and pterostilbene, a combination that has been proven to boost the mean concentrations of nicotinamide adenine dinucleotide in its regular users.

How can consumers be certain of the above claim?

Virtually everyone familiar with supplements understands that they are not evaluated by the United States Food and Drug Administration, the same organization that carries out clinical trials on brand-new medications and recently-developed formulations of existing medications.

While Basis is not approved by the US FDA – much like any supplement on today’s market – its efficacy has been proven by a clinical trial funded by its manufacturer.

We’ll delve into the details of this clinical trial more deeply in following paragraphs.

What do the components of Basis do?

The function of pterostilbene and nicotinamide riboside is quite simple: nicotinamide riboside is converted into NAD+ – that’s nicotinamide adenine dinucleotide – in the body after it’s ingested. As long as NAD+ is present in sufficient quantities, pterostilbene can distribute proteins called sirtuins throughout cells that make up the human body.

Basis has four other components, and are as follows: hypromellose, silica, vegetable magnesium stearate, and microcrystalline cellulose. All of the above ingredients are either used in the capsule that holds together Basis’ two central components, or to extend the life of the supplement when stored.

The central idea behind the need for Basis is that the natural stores of NAD+ fade away in the human body as we get older. Children and young adults are full of NAD+, although such concentrations steadily drop over time, demoting cellular health, circadian rhythms, and other bodily functions. Rather than surrendering to our bodies’ natural aging process, the regular, once-daily consumption of Basis is alleged to improve stores of NAD+, in turn promoting cellular health.

What did the clinical trial mentioned earlier indicate?

120 people participated in the clinical trial. As all proper clinical trials are supposed to be, it was performed as a double-blinded, randomized, and controlled by placebo.

Healthy people between the ages of 60 and 80 were given either:

  • A placebo
  • 250 mg of nicotinamide riboside and 50 mg of pterostilbene
  • 500 mg of nicotinamide riboside and 100 mg of pterostilbene

After four weeks, blood concentrations of NAD+ in the second group rose an average of 40 percent. Those in the third group rose a whopping 90 percent. As such, Elysium Health recommends healthy adults to take two capsules – equivalent to the third dosage seen above – per day.

Visit Elysium Health on